This brand name is authorized in Finland, Japan, Mexico
The drug LAXOBERON contains one active pharmaceutical ingredient (API):
|
1
Sodium picosulfate
UNII LR57574HN8 - SODIUM PICOSULFATE
|
|
Sodium picosulfate is a locally acting laxative from the triarylmethane group, which after bacterial cleavage in the colon, has a dual-action with stimulation of the mucosa of both the large intestine and of the rectum. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A06AB08 | Sodium picosulfate | A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AB Contact laxatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 066669, 439786 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2359005F1218, 2359005S1240 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 78550 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
